
Summary:
India’s healthcare and pharmaceutical industry has seen remarkable investment inflows totalling Rs. 2,61,900 crore (US$ 30 billion) from 2022 to 2024, with hospitals emerging as a primary driver of this growth. According to a report by Grant Thornton Bharat and the Association of Healthcare Providers of India (AHPI), hospitals played a crucial role, accounting for Rs. 58,840 crore (US$ 6.74 billion) in merger and acquisition (M&A) deals and Rs. 43,310 crore (US$ 4.96 billion) from private equity (PE) investments, making up 40% and 38% of total transactions, respectively. Hospitals also raised Rs. 4,070 crore (US$ 466 million) through initial public offerings (IPOs) and through foreign direct investment (FDI) in healthcare and diagnostics Rs. 27,140 crore (US$ 3.2 billion) was raised.
The report points to increasing consolidation among multispecialty hospitals and the rising adoption of advanced technology as major factors driving investor interest. Additionally, single-specialty segments like nephrology, oncology and in-vitro fertilisation (IVF) attracted PE investments worth Rs. 12,220 crore (US$ 1.4 billion) over the two year period. Despite this growth, challenges remain, particularly the uneven distribution of healthcare infrastructure, with 60% of hospital beds concentrated in metro cities while 70% of the population lives in non-metro areas. Addressing these gaps through digital health innovation, rural healthcare development and creative financing models will be essential for achieving balanced healthcare access nationwide.
Source: IBEF
Disclaimer: The information on this website comes from the India Brand Equity Foundation (IBEF), a reliable source for thorough insights into numerous areas of the Indian economy. While we aim to offer accurate and up-to-date information, the views, opinions and analyses stated herein are solely those of the authors and contributors and do not necessarily represent IBEF's official stance or position. Readers should check information from credible sources and use their own discretion when relying on content provided on this site. We assume no responsibility or liability for the supplied content, including its accuracy, completeness and usefulness.